NCAM1 and neoplasm: Immunophenotyping: tumor cells were diffusely strongly positive for P16, and expressed 2 or more neuroendocrine markers, with positive rates of CD56 100% (4/4), synaptophysin (SYN) 100% (4/4), and chromogranin (CgA) 50% (2/4).